Stay updated on Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov interface as revision v3.8.0 instead of v3.7.2. The study record content is unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T14:14:00.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates about a terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.6%
    Check dated 2026-10-25T13:27:53.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:58:19.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The trial’s record history now includes a version submitted October 1, 2026, documenting a Study Status update. The record’s latest posted-update date is October 5, 2026.
    Difference
    0.4%
    Check dated 2026-10-11T14:43:27.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the study record history, replacing the previous v3.6.6 entry. This updates the historical versioning of the record without changing the study details.
    Difference
    0.1%
    Check dated 2026-09-20T20:41:59.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 appears in the Record History, replacing the previous v3.6.5, signaling a minor update to the page’s release notes.
    Difference
    0.1%
    Check dated 2026-08-30T21:39:26.000Z thumbnail image

Stay in the know with updates to Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.